Moreover, previous studies demonstrated that SV ameliorated heart failure [32] and other cardiovascular events by activating Peroxisome-proliferator-activated receptor gamma (PPARγ)-dependent pathways [33], and modulation of PPARγ signals helps provide pleiotropic protection of SV [34]. The gene discussed is PPARG; the disease is heart failure.